UBS Group
CAH icon

UBS Group’s Cardinal Health CAH Stock Holding History

UBS Group’s Portfolio CAH Stock Details CAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.68M Sell
15,500
-28,200
-65% -$5.86M ﹤0.01% 4481
2026
Q1 		$9.23M Buy
43,700
+100
+0.2% +$21.5K ﹤0.01% 3445
2025
Q4 		$8.96M Buy
43,600
+8,900
+26% +$1.67M ﹤0.01% 3406
2025
Q3 		$5.45M Buy
34,700
+32,800
+1,726% +$5.07M ﹤0.01% 3947
2025
Q2 		$319K Sell
1,900
-1,300
-41% -$193K ﹤0.01% 6394
2025
Q1 		$441K Sell
3,200
-28,800
-90% -$3.67M ﹤0.01% 5950
2024
Q4 		$3.78M Hold
32,000
– – ﹤0.01% 4121
2024
Q3 		$3.54M Hold
32,000
– – ﹤0.01% 3423
2024
Q2 		$3.15M Buy
32,000
+2,000
+7% +$204K ﹤0.01% 3302
2024
Q1 		$3.36M Buy
+30,000
New +$3.24M ﹤0.01% 3394
2020
Q3 		– Sell
-6,800
Closed -$355K – 8005
2020
Q2 		$355K Sell
6,800
-8,500
-56% -$438K ﹤0.01% 4395
2020
Q1 		$733K Buy
+15,300
New +$794K ﹤0.01% 3630
2019
Q2 		– Sell
-64,600
Closed -$3.11M – 7866
2019
Q1 		$3.11M Buy
64,600
+52,100
+417% +$2.61M ﹤0.01% 2597
2018
Q4 		$558K Buy
+12,500
New +$652K ﹤0.01% 4176
2017
Q4 		– Sell
-7,500
Closed -$502K – 7845
2017
Q3 		$502K Buy
+7,500
New +$530K ﹤0.01% 4213
2017
Q1 		– Sell
-44,100
Closed -$3.17M – 7650
2016
Q4 		$3.17M Sell
44,100
-10,200
-19% -$737K ﹤0.01% 2506
2016
Q3 		$4.22M Buy
54,300
+38,200
+237% +$3.09M ﹤0.01% 2175
2016
Q2 		$1.26M Buy
+16,100
New +$1.28M ﹤0.01% 3176
2015
Q3 		– Sell
-33,500
Closed -$2.8M – 8414
2015
Q2 		$2.8M Buy
+33,500
New +$2.96M ﹤0.01% 2650
2015
Q1 		– Sell
-1,900
Closed -$153K – 8847
2014
Q4 		$153K Buy
+1,900
New +$150K ﹤0.01% 5289

Other funds holding CAH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

UBS Group's CAH Position: Q2 2026 in Review

UBS Group increased its Cardinal Health (CAH) stake by 9.7% in Q2 2026, buying an estimated $16.9M and bringing the position to 920,950 shares worth $219M. The position accounts for 0.03% of the portfolio, ranked #616.

UBS Group first reported a position in CAH in Q4 2014 and has held it in 47 quarters since. 1,499 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • UBS Group held 920,950 shares of Cardinal Health worth $219M as of Q2 2026.
  • UBS Group bought 81,381 Cardinal Health shares in Q2 2026, an estimated $16.9M.
  • Cardinal Health made up 0.03% of UBS Group's portfolio in Q2 2026, its #616 holding.
  • UBS Group first reported a position in Cardinal Health in Q4 2014 and has held it in 47 quarters since.
  • 1,499 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.